RxDoctor Payments DataLook up a doctor →

Kenneth Walters, MD

Pulmonary Disease · Anderson, SCNPI 1366679458

Payments from drug & device makers

$80,526in general payments, 2019–2025

Across 506 payments — averaging $159.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$67K
  • Intuitive Surgical$7K
  • GSK$1K
  • Boehringer Ingelheim$784
  • Actelion Pharmaceuticals US, Inc.$331
  • Merck$323
  • plus $4K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca151$67,064
Intuitive Surgical9$7,096
GSK80$1,015
Boehringer Ingelheim43$784
Actelion Pharmaceuticals US, Inc.15$331
Merck18$323
Insmed, Inc.20$309
United Therapeutics Corporation14$307
Pinnacle Biologics, Inc1$300
Electromed, Inc.25$265
Sanofi9$248
Grifols USA, LLC13$236
Takeda Pharmaceuticals U.S.A., Inc.8$223
Genentech USA, Inc.8$123
Axsome Therapeutics, Inc.5$120
Novartis6$105
Amgen5$105
Regeneron Healthcare Solutions, Inc.4$102
Philips North America LLC5$101
Galvanize Therapeutics, Inc1$98
Mallinckrodt Hospital Products Inc.4$84
Johnson & Johnson5$73
Mylan Specialty L.p.4$70
Pharming Healthcare, Inc.3$69
Verona Pharma, Inc.3$64
Viatris Specialty LLC3$60
Harmony Biosciences LLC3$59
Advanced Respiratory, Inc4$58
Sanofi-aventis U.S. LLC1$57
Inari Medical, Inc.1$49
Fisher & Paykel Healthcare Inc2$46
Vifor Pharma, Inc.2$36
Ambu Inc.1$35
Lilly USA, LLC2$30
Baxter Healthcare1$27
CSL Behring1$25
Incyte Corporation2$24
Biofire Diagnostics, LLC1$24
Ipsen Biopharmaceuticals, Inc1$23
ANI Pharmaceuticals, Inc.1$21
Covis Pharma GmbH1$20
Seagen Inc.1$20
ADC Therapeutics America, Inc.1$19
Acrotech Biopharma Inc.1$19
Bard Peripheral Vascular, Inc.1$18
Myriad Genetic Laboratories, Inc.1$18
Biogen1$18
Circassia Inc.1$17
Healthmyne, Inc.1$17
Astellas Pharma US Inc1$16
Coherus Oncology, Inc.1$16
Applied Medical Technology Inc1$15
AbbVie1$15
Teva Pharmaceuticals USA, Inc.1$14
Resmed Corp1$14
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$14
Olympus America Inc.1$14
E.r. Squibb & Sons, L.L.C.1$13
Itamar Medical Inc1$13
Gilead1$12

How this compares

$80,526 in reported general payments places this provider in the 85th percentile of 192 pulmonary disease providers in South Carolina.

See all pulmonary disease providers in South Carolina

Medicare billing

Part B allowed, 2024
$167,630
Medicare patients
596
Services billed
1,974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →